US20020022056A1
(en)
|
1997-02-14 |
2002-02-21 |
Burkhard Schlutermann |
Oxacarbazepine film-coated tablets
|
PL374778A1
(en)
*
|
2002-05-31 |
2005-10-31 |
Desitin Arzneimittel Gmbh |
Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
|
CA2494660A1
(en)
*
|
2002-08-06 |
2004-02-19 |
Novartis Ag |
Use of carboxamides for the treatment of tinnitus
|
GB0221956D0
(en)
*
|
2002-09-20 |
2002-10-30 |
Novartis Ag |
Organic compounds
|
BRPI0414112A
(pt)
*
|
2003-09-03 |
2006-10-31 |
Novartis Ag |
uso de oxcarbazepina para o tratamento de dor neuropática diabética e a melhora do sono
|
PE20060124A1
(es)
*
|
2004-03-22 |
2006-03-07 |
Novartis Ag |
Tabletas de desintegracion que comprenden licarbazepina
|
US20090196919A1
(en)
*
|
2004-10-25 |
2009-08-06 |
Ajay Singla |
Oxcarbazepine dosage forms
|
US20060252745A1
(en)
|
2005-05-06 |
2006-11-09 |
Almeida Jose L D |
Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
|
US20090143360A1
(en)
*
|
2005-07-08 |
2009-06-04 |
Muhammed Safadi |
Oxcarbazepine Formulation
|
WO2007029093A2
(en)
*
|
2005-09-05 |
2007-03-15 |
Ranbaxy Laboratories Limited |
Pharmaceutical dosage forms of oxcarbazepine
|
CN101336105A
(zh)
*
|
2006-01-31 |
2008-12-31 |
特瓦制药工业有限公司 |
奥卡西平药物制剂及其制备方法,其中奥卡西平具有宽且多峰的粒度分布
|
AU2007211210A1
(en)
*
|
2006-01-31 |
2007-08-09 |
Teva Pharmaceutical Industries Ltd. |
Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
|
ES2360423T3
(es)
*
|
2006-04-26 |
2011-06-03 |
Supernus Pharmaceuticals, Inc. |
Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal.
|
US20080138403A1
(en)
*
|
2006-12-08 |
2008-06-12 |
Sun Pharmaceutical Industries Ltd. |
Pharmaceutical dosage forms of oxcarbazepine
|
GB0700773D0
(en)
|
2007-01-15 |
2007-02-21 |
Portela & Ca Sa |
Drug therapies
|
EP2918578A1
(en)
|
2007-03-16 |
2015-09-16 |
Concert Pharmaceuticals, Inc. |
Inhibitors of cholesterol ester transfer protein
|
US8198305B2
(en)
*
|
2007-04-13 |
2012-06-12 |
Concert Pharmaceuticals Inc. |
1,2-benzisoxazol-3-yl compounds
|
BRPI0810362A2
(pt)
*
|
2007-04-19 |
2014-10-29 |
Concert Pharmaceuticals Inc |
Compostos de morfolinila deuterados
|
WO2008133949A1
(en)
|
2007-04-25 |
2008-11-06 |
Concert Pharmaceuticals, Inc. |
Analogues of cilostazol
|
WO2008137461A1
(en)
|
2007-05-01 |
2008-11-13 |
Concert Pharmaceuticals Inc. |
Naphthyl(ethyl) acetamides
|
PL2522668T3
(pl)
|
2007-05-01 |
2015-07-31 |
Concert Pharmaceuticals Inc |
Związki morfinanu
|
FI3825306T3
(fi)
|
2007-05-01 |
2023-08-23 |
Concert Pharmaceuticals Inc |
Morfinaaniyhdisteitä
|
EP3632916B1
(en)
|
2007-05-01 |
2022-06-08 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
ES2395137T3
(es)
|
2007-06-12 |
2013-02-08 |
Concert Pharmaceuticals, Inc. |
Derivados de azapéptidos como inhibidores de la proteasa VIH
|
US8410124B2
(en)
*
|
2007-10-18 |
2013-04-02 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
JP5567503B2
(ja)
|
2008-02-29 |
2014-08-06 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換キサンチン誘導体
|
US20110160253A1
(en)
*
|
2008-05-28 |
2011-06-30 |
Harbeson Scott L |
Deuterated tizanidine
|
US20100221221A1
(en)
*
|
2008-08-12 |
2010-09-02 |
Concert Pharmaceuticals Inc. |
N-phenyl-2-pyrimidineamine derivatives
|
EP2634187B1
(en)
|
2008-09-19 |
2014-11-12 |
Concert Pharmaceuticals Inc. |
Deuterated morphinan compounds
|
EP2364151A1
(en)
|
2008-10-30 |
2011-09-14 |
Concert Pharmaceuticals Inc. |
Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
|
DK2397158T3
(en)
|
2008-10-30 |
2016-07-25 |
Concert Pharmaceuticals Inc |
COMBINATION OF MORPHINANFORBINDELSER AND antidepressants in treating pseudobulbar affect
|
CA2742509A1
(en)
|
2008-11-04 |
2010-05-14 |
Anchor Therapeutics, Inc. |
Cxcr4 receptor compounds
|
WO2010065755A1
(en)
|
2008-12-04 |
2010-06-10 |
Concert Pharmaceuticals, Inc. |
Deuterated pyridinones
|
US20110053961A1
(en)
|
2009-02-27 |
2011-03-03 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
EP2408771B1
(en)
|
2009-03-17 |
2016-11-16 |
Concert Pharmaceuticals, Inc. |
Pyrazinoisoquinoline compounds
|
US20120244122A1
(en)
|
2009-05-28 |
2012-09-27 |
Masse Craig E |
Peptides for the Treatment of HCV Infections
|
JP2012531419A
(ja)
|
2009-06-23 |
2012-12-10 |
コンサート ファーマシューティカルズ インコーポレイテッド |
Gaba−a受容体修飾物質としての重水素修飾されたトリアゾロピリダジン誘導体
|
US20110015154A1
(en)
*
|
2009-07-20 |
2011-01-20 |
Kellermann Gottfried H |
Supporting acetylcholine function
|
US8278460B2
(en)
|
2009-10-15 |
2012-10-02 |
Concert Pharmaceuticals, Inc. |
Substituted benzimidazoles
|
US20110098265A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Neuroscience, Inc. |
Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
|
WO2011060216A1
(en)
|
2009-11-12 |
2011-05-19 |
Concert Pharmaceuticals Inc. |
Substituted azaindoles
|
EP2536696A1
(en)
|
2010-02-18 |
2012-12-26 |
Concert Pharmaceuticals Inc. |
Pyrimidine derivatives
|
WO2011106703A2
(en)
|
2010-02-26 |
2011-09-01 |
Anchor Therapeutics, Inc. |
Cxcr4 receptor compounds
|
EP3144296A1
(en)
|
2010-03-02 |
2017-03-22 |
Concert Pharmaceuticals, Inc. |
Deuterated tetrahydronaphthalene derivatives
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
WO2012037060A1
(en)
|
2010-09-13 |
2012-03-22 |
Concert Pharmaceuticals Inc. |
Substituted azaindoles
|
WO2012065028A2
(en)
|
2010-11-11 |
2012-05-18 |
Concert Pharmaceuticals Inc. |
Substituted tetracyclines
|
WO2012079075A1
(en)
|
2010-12-10 |
2012-06-14 |
Concert Pharmaceuticals, Inc. |
Deuterated phthalimide derivatives
|
US8447329B2
(en)
|
2011-02-08 |
2013-05-21 |
Longsand Limited |
Method for spatially-accurate location of a device using audio-visual information
|
EP2678337A1
(en)
|
2011-02-25 |
2014-01-01 |
Concert Pharmaceuticals Inc. |
2-amino-naphthyridine derivatives
|
WO2012129381A1
(en)
|
2011-03-22 |
2012-09-27 |
Concert Pharmaceuticals Inc. |
Deuterated preladenant
|
WO2012151361A1
(en)
|
2011-05-03 |
2012-11-08 |
Concert Pharmaceuticals Inc. |
Carbamoylpyridone derivatives
|
US20140128469A1
(en)
|
2011-05-10 |
2014-05-08 |
Concert Pharmaceuticals Inc. |
Deuterated n-butyl bumetanide
|
PL3235812T3
(pl)
|
2011-05-18 |
2020-04-30 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterowane pochodne iwakaftoru
|
WO2013013052A1
(en)
|
2011-07-19 |
2013-01-24 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
WO2013106437A1
(en)
|
2012-01-09 |
2013-07-18 |
Anchor Therapeutics, Inc. |
Apj receptor compounds
|
WO2013130849A1
(en)
|
2012-02-29 |
2013-09-06 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
KR20150002779A
(ko)
|
2012-04-13 |
2015-01-07 |
콘서트 파마슈티컬즈, 인크. |
치환된 크산틴 유도체
|
WO2013159026A1
(en)
|
2012-04-20 |
2013-10-24 |
Concert Pharmaceuticals, Inc. |
Deuterated rigosertib
|
PL3450434T3
(pl)
|
2012-06-15 |
2021-10-04 |
Concert Pharmaceuticals, Inc. |
Deuterowane pochodne ruksolitynibu
|
WO2014012009A1
(en)
|
2012-07-12 |
2014-01-16 |
Concert Pharmaceuticals, Inc. |
Deuterated idebenone
|
ES2717279T3
(es)
|
2012-08-17 |
2019-06-20 |
Concert Pharmaceuticals Inc |
Baricitinib deuterada
|
WO2014078842A1
(en)
|
2012-11-19 |
2014-05-22 |
Concert Pharmaceuticals, Inc. |
Deuterated cftr potentiators
|
EP2935251A1
(en)
|
2012-12-20 |
2015-10-28 |
Concert Pharmaceuticals Inc. |
Deuterated alk inhibitors
|
WO2014100733A1
(en)
|
2012-12-21 |
2014-06-26 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating calcific aortic valve stenosis
|
WO2014110322A2
(en)
|
2013-01-11 |
2014-07-17 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
EP2968268B1
(en)
|
2013-03-15 |
2020-07-29 |
Concert Pharmaceuticals Inc. |
Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
|
JP2016512831A
(ja)
|
2013-03-15 |
2016-05-09 |
コンサート ファーマシューティカルズ インコーポレイテッド |
重水素化されたパルボシクリブ
|
HU231191B1
(hu)
|
2013-04-15 |
2021-08-30 |
Szegedi Tudományegyetem |
Izotóp tartalmú morfin molekulák
|
US20160159861A1
(en)
|
2013-07-18 |
2016-06-09 |
Anchor Therapeutics, Inc. |
APJ Receptor Compounds
|
WO2015009889A1
(en)
|
2013-07-18 |
2015-01-22 |
Concert Pharmaceuticals, Inc. |
Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
|
US9676790B2
(en)
|
2013-08-30 |
2017-06-13 |
Concert Pharmaceuticals, Inc. |
Substituted thienotriazolodiazapines
|
WO2015063670A1
(en)
*
|
2013-10-30 |
2015-05-07 |
Wockhardt Limited |
Solid oral modified-release composition comprising oxcarbazepine or a pharmaceutically acceptable salt thereof
|
JP6526060B2
(ja)
|
2014-02-10 |
2019-06-05 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換トリアゾロベンゾジアゼピン
|
CA2981791A1
(en)
|
2014-04-18 |
2015-10-22 |
Concert Pharmaceuticals, Inc. |
Methods of treating hyperglycemia
|
WO2015179772A1
(en)
|
2014-05-23 |
2015-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated phenylquinazolinone and phenylisoquinolinone compounds
|
BR112016028119A2
(pt)
|
2014-06-06 |
2017-08-22 |
Res Triangle Inst |
Agonistas receptores de apelina (apj) e usos dos mesmos
|
US10301273B2
(en)
|
2014-08-07 |
2019-05-28 |
Mayo Foundation For Medical Education And Research |
Compounds and methods for treating cancer
|
WO2016061488A1
(en)
|
2014-10-17 |
2016-04-21 |
Concert Pharmaceuticals, Inc. |
Amine reuptake inhibitors
|
WO2016073545A1
(en)
|
2014-11-06 |
2016-05-12 |
Concert Pharmaceuticals, Inc. |
Phenyloxadiazole benzoic acids
|
WO2016089814A1
(en)
|
2014-12-02 |
2016-06-09 |
Concert Pharmaceuticals, Inc. |
Deuterated analogues of daclatasvir
|
WO2016105547A1
(en)
|
2014-12-24 |
2016-06-30 |
Concert Pharmaceuticals, Inc. |
Deuterated dasabuvir
|
WO2016109795A1
(en)
|
2014-12-31 |
2016-07-07 |
Concert Pharmaceuticals, Inc. |
Deuterated funapide and difluorofunapide
|
US20180044375A1
(en)
|
2015-03-06 |
2018-02-15 |
Concert Pharmaceuticals, Inc. |
Deuterated emricasan
|
EP3277647A1
(en)
|
2015-03-31 |
2018-02-07 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated vx-661
|
US10683305B2
(en)
|
2015-04-27 |
2020-06-16 |
Concert Pharmaceuticals, Inc. |
Deuterated OTX-015
|
WO2017020005A1
(en)
|
2015-07-30 |
2017-02-02 |
Concert Pharmaceuticals, Inc. |
Morphinan compounds for use in treating agitation
|
US20180243289A1
(en)
|
2015-07-30 |
2018-08-30 |
Concert Pharmaceuticals, Inc. |
Deuterated morphinan compounds for treating agitation
|
RU2761344C2
(ru)
|
2015-09-21 |
2021-12-07 |
Вертекс Фармасьютикалз (Юроп) Лимитед |
Введение дейтерированных усилителей cftr
|
US11267777B2
(en)
|
2015-11-19 |
2022-03-08 |
Concert Pharmaceuticals, Inc. |
Deuterated EPI-743
|
RU2766148C1
(ru)
|
2015-12-09 |
2022-02-08 |
Рисерч Трайэнгл Инститьют |
Улучшенные агонисты апелинового рецептора (apj) и их использование
|
WO2017147003A1
(en)
|
2016-02-26 |
2017-08-31 |
Novobiotic Pharmaceuticals, Llc |
Novel macrocyclic antibiotics and uses thereof
|
KR20230086814A
(ko)
|
2016-05-04 |
2023-06-15 |
콘서트 파마슈티컬즈, 인크. |
중수소화된 jak 저해제를 이용한 탈모 장애의 치료
|
KR20230017361A
(ko)
|
2016-07-04 |
2023-02-03 |
아바니르 파마슈티컬스, 인코포레이티드 |
중수소화 덱스트로메토르판의 합성 방법
|
WO2018026833A1
(en)
|
2016-08-01 |
2018-02-08 |
The Brigham And Women's Hospital, Inc. |
Particles for delivery of proteins and peptides
|
WO2018160717A1
(en)
|
2017-02-28 |
2018-09-07 |
Mayo Foundation For Medical Education And Research |
Compounds and methods for treating cancer
|
US11278025B2
(en)
|
2017-05-17 |
2022-03-22 |
The General Hospital Corporation |
Antibiotic compounds
|
KR102650538B1
(ko)
|
2017-05-19 |
2024-03-21 |
수퍼브 위즈덤 리미티드 |
레시퀴모드의 유도체
|
CA3082834A1
(en)
|
2017-11-22 |
2019-05-31 |
Concert Pharmaceuticals, Inc. |
Deuterated analogs of d-serine and uses thereof
|
US11243207B2
(en)
|
2018-03-29 |
2022-02-08 |
Mayo Foundation For Medical Education And Research |
Assessing and treating cancer
|
WO2021236139A1
(en)
|
2020-05-21 |
2021-11-25 |
Concert Pharmaceuticals, Inc. |
Novel deuterated jak inhibitor and uses thereof
|
MX2023005027A
(es)
|
2020-10-28 |
2023-07-31 |
Sun Pharmaceutical Ind Inc |
Regimenes para el tratamiento de los trastornos de la perdida de cabello con inhibidores de jak deuterados.
|
CN118159272A
(zh)
|
2021-08-11 |
2024-06-07 |
太阳医药工业公司 |
用氘化的jak抑制剂来治疗脱发病症
|
CA3228509A1
(en)
|
2021-08-12 |
2023-02-16 |
Sun Pharmaceutical Industries, Inc. |
Treatment of jak-inhibition-responsive disorders with prodrugs of jak inhibitors
|
WO2023215520A1
(en)
|
2022-05-04 |
2023-11-09 |
Sun Pharmaceutical Industries, Inc. |
Dosage regimens for treatment with deuterated jak inhibitors
|